Santhera Pharmaceuticals Holding AG operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Santhera Pharmaceuticals Holding AG with three other
pharmaceutical manufacturers in Europe:
Celon Pharma SA
sales of 125.24 million Polish New Zlotys [US$32.12 million]
(31.21 million Euro [US$34.34 million]
of which 56%
was Sale of Goods), and
Summit Therapeutics PLC
based in the United Kingdom
(£25.42 million [US$32.67 million]
of which 100%
was Drug Discovery).
During the year ended December of 2018, sales at
Santhera Pharmaceuticals Holding AG were 31.66 million Swiss Francs (US$31.98 million).
increase of 38.0%
versus 2017, when the company's sales were 22.94 million Swiss Francs.
This was the fifth consecutive year of sales increases at Santhera Pharmaceuticals Holding AG
(and since 2013, sales have increased a total of 2,300%).